Answers are grounded in this paper and cite their sources.
Noninfectious intermediate uveitis, posterior uveitis, or panuveitis, particularly persistent disease, is associated with a substantial risk of ocular complications. Optimal treatment initiatives remain imperative to reduce the ocular complication-related burden of NIIPPU.
No takes yet. Share an insight, caveat, or question.
Dick et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: